Wang N - Search Results

1

XRCC3 and RAD51 expression are associated with clinical factors in breast cancer.

Hu J, Wang N, Wang YJ. Hu J, et al. Among authors: wang yj, wang n. PLoS One. 2013 Aug 20;8(8):e72104. doi: 10.1371/journal.pone.0072104. eCollection 2013. PLoS One. 2013. PMID: 23977219 Free PMC article.

2

[Comparison of clinicopathologic characteristics and prognosis of triple-negative with Her-2-overexpressing breast cancer].

Wang YJ, Wang N, Wang B, Qin WX, Xue CY. Wang YJ, et al. Among authors: wang n, wang b. Zhonghua Zhong Liu Za Zhi. 2009 May;31(5):346-50. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19799082 Chinese.

3

Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma.

Ying M, Li D, Yang L, Wang M, Wang N, Chen Y, He M, Wang Y. Ying M, et al. Among authors: wang y, wang n, wang m. J Cancer Res Clin Oncol. 2010 Oct;136(10):1617-26. doi: 10.1007/s00432-010-0819-6. Epub 2010 Feb 14. J Cancer Res Clin Oncol. 2010. PMID: 20155426

4

Estrogen receptor positive operable breast cancer: does menopausal status impact on HER2 and progesterone receptor status?

Wang N, Wang B, Wang Y, Hu J. Wang N, et al. Among authors: wang y, wang b. Breast. 2011 Dec;20(6):519-24. doi: 10.1016/j.breast.2011.05.009. Epub 2011 Jun 22. Breast. 2011. PMID: 21700456 Free article.

5

Correlation of FANCM expression with clinical factors in luminal B breast cancer.

Wang Y, Wang J, Long F, Wang N, Zhang B, Han H, Wang Y. Wang Y, et al. Among authors: wang j, wang n. Breast Cancer. 2018 Jul;25(4):431-437. doi: 10.1007/s12282-018-0841-0. Epub 2018 Jan 31. Breast Cancer. 2018. PMID: 29388117

6

[Effect of vascular endothelial growth factor antibody Avastin on angiogenesis of human gastric cancer growing orthotopically in nude mice].

Wang N, Wang B, Wang YJ. Wang N, et al. Among authors: wang yj, wang b. Ai Zheng. 2006 Sep;25(9):1076-81. Ai Zheng. 2006. PMID: 16965645 Chinese.

7

[Phase II study of docetaxel plus epirubicin versus docetaxel plus cisplatin as first-line chemotherapy for advanced breast cancer].

Wang YJ, Wu Q, Su FX, Zhou LZ, Ye ZB, Yang JQ, Ren H, Zhang J, Ding G, Fu Q, Wang N. Wang YJ, et al. Among authors: wang n. Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):541-4. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19062725 Clinical Trial. Chinese.

8

GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis.

Hu J, Zhou GW, Wang N, Wang YJ. Hu J, et al. Among authors: wang yj, wang n. Breast Cancer Res Treat. 2010 Nov;124(2):425-31. doi: 10.1007/s10549-010-0841-z. Epub 2010 Mar 21. Breast Cancer Res Treat. 2010. PMID: 20306294

9

MTRR A66G polymorphism and breast cancer risk: a meta-analysis.

Hu J, Zhou GW, Wang N, Wang YJ. Hu J, et al. Among authors: wang yj, wang n. Breast Cancer Res Treat. 2010 Dec;124(3):779-84. doi: 10.1007/s10549-010-0892-1. Epub 2010 Apr 22. Breast Cancer Res Treat. 2010. PMID: 20411324

10

Mitochondrial transcription factor A contributes to cisplatin resistance in patients with estrogen receptor‑positive breast cancer.

Gao W, Wu MH, Wang N, Ying MZ, Zhang YY, Hua J, Chuan L, Wang YJ. Gao W, et al. Among authors: wang yj, wang n. Mol Med Rep. 2016 Dec;14(6):5304-5310. doi: 10.3892/mmr.2016.5881. Epub 2016 Oct 25. Mol Med Rep. 2016. PMID: 27779689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,011 results

Search Page

Filters